Category: Uncategorized

15. March 2021

|

ODD for the application against ALS and capital increase 2021

Both the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) approved InnoMedica’s …

Read more

27. February 2021

|

Winter-Update

InnoMedica is close to submission of the marketing authorization application for its chemotherapy and plans to …

Read more